Company / Cost of Revenue
OptimizeRx Corp Cost of Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$32.7M
FY2025
5-year range
$19.2M / $32.7M
FY2021-FY2025
Trend
+14.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $23M to $33M over the past 2 years.
Based on SEC 10-K filings.
$33M in FY2025 with a 5-year CAGR of +29.0%.
Increased from $23M to $33M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- +29.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +29.0%, indicating consistent growth.
- In FY2025, cost of revenue increased 14.4% year-over-year.
- Lowest cost of revenue in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.7M | +14.4% |
| FY2024 | $28.6M | +21.9% |
| FY2023 | $23.5M | -8.5% |
| FY2022 | $25.7M | +33.6% |
| FY2021 | $19.2M | +109.7% |
| FY2020 | $9.2M | +1.8% |
| FY2019 | $9.0M | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026